Global Transdermal Drug Patches Market Report, History and Forecast 2017-2028

Due to the COVID-19 pandemic, the global Transdermal Drug Patches market size was value at US$ 6,680.25 million in 2021 and is forecast to be a readjusted size of US$ 7630.01 million by 2028 with a CAGR of 1.86% during the forecast period 2022-2028.

The global main manufacturers of Transdermal Drug Patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grunenthal, and IBSA Group, etc. In 2021, the global six largest players have a share approximately 41.80% in terms of revenue.

The North America Transdermal Drug Patches market size was US$ 3,340.28 million in 2021, while China was about US$ 288.23 million. The proportion of the China was 4.31% in 2021 and it is predicted that the share will reach 8.89% in 2028, trailing a CAGR of 12.34% through the analysis period.

Fully considering the economic change by the COVID-19, Methyl Salicylate-based Patch accounting for 13.17% of the Transdermal Drug Patches global market in 2021, is projected to value US$ 800.46 million by 2028, growing at a revised -0.91% CAGR from 2022 to 2028. While Rx Channel segment is altered to an 1.77% CAGR throughout this forecast period and will hold a share about 93.49% in 2028.

Scope and Market Size:

The global Transdermal Drug Patches market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.

Segment by Type

Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Segment by Application

Rx Channel
OTC Channel

By Company

Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grunenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy's Laboratories

By Region

North America
- U.S.
- Canada
- Mexico

Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- SEA

Europe
- Germany
- France
- U.K.
- Italy
- Spain

South America
- Brazil
- Argentina

Middle East & Africa
- Saudi Arabia
- UAE
- Turkey
- South Africa

1 TRANSDERMAL DRUG PATCHES MARKET OVERVIEW

1.1 TRANSDERMAL DRUG PATCHES PRODUCT OVERVIEW
1.2 TRANSDERMAL DRUG PATCHES MARKET SEGMENT BY TYPE
- 1.2.1 METHYL SALICYLATE-BASED PATCH
- 1.2.2 RIVASTIGMINE TRANSDERMAL PATCH
- 1.2.3 FENTANYL TRANSDERMAL PATCH
- 1.2.4 LIDOCAINE PATCH
- 1.2.5 DICLOFENAC PATCH
- 1.2.6 NICOTINE TRANSDERMAL PATCH
1.3 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE BY TYPE
- 1.3.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE OVERVIEW BY TYPE (2017-2028)
- 1.3.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022)
- 1.3.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY TYPE (2023-2028)
1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE
- 1.4.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.2 EUROPE TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.3 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.4 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.5 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)

2 TRANSDERMAL DRUG PATCHES MARKET COMPETITION BY COMPANY

2.1 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES SALES (2017-2022)
2.2 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES REVENUE (2017-2022)
2.3 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES PRICE (2017-2022)
2.4 GLOBAL TOP MANUFACTURERS TRANSDERMAL DRUG PATCHES MANUFACTURING BASE DISTRIBUTION, SALES AREA, PRODUCT TYPE
2.5 TRANSDERMAL DRUG PATCHES MARKET COMPETITIVE SITUATION AND TRENDS
- 2.5.1 TRANSDERMAL DRUG PATCHES MARKET CONCENTRATION RATE
- 2.5.2 GLOBAL 5 LARGEST MANUFACTURERS BY TRANSDERMAL DRUG PATCHES REVENUE IN 2021
2.6 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN TRANSDERMAL DRUG PATCHES AS OF 2021)
2.7 KEY MANUFACTURERS TRANSDERMAL DRUG PATCHES PRODUCT OFFERED
2.8 MERGERS & ACQUISITIONS, EXPANSION

3 TRANSDERMAL DRUG PATCHES STATUS AND OUTLOOK BY REGION

3.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE AND CAGR BY REGION: 2017 VS 2022 VS 2028
3.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY REGION
- 3.2.1 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2017-2022)
- 3.2.2 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2017-2022)
- 3.2.3 GLOBAL TRANSDERMAL DRUG PATCHES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2017-2022)
3.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY REGION
- 3.3.1 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2023-2028)
- 3.3.2 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2023-2028)
- 3.3.3 GLOBAL TRANSDERMAL DRUG PATCHES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2023-2028)

4 TRANSDERMAL DRUG PATCHES BY APPLICATION

4.1 TRANSDERMAL DRUG PATCHES MARKET SEGMENT BY APPLICATION
- 4.1.1 RX CHANNEL
- 4.1.2 OTC CHANNEL
4.2 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE BY APPLICATION
- 4.2.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE OVERVIEW BY APPLICATION (2017-2028)
- 4.2.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022)
- 4.2.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
4.3 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION
- 4.3.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.2 EUROPE TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.3 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.4 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.5 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)

5 NORTH AMERICA TRANSDERMAL DRUG PATCHES BY COUNTRY

5.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
- 5.1.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
- 5.1.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
5.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
- 5.2.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
- 5.2.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)

6 EUROPE TRANSDERMAL DRUG PATCHES BY COUNTRY

6.1 EUROPE TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
- 6.1.1 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
- 6.1.2 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
6.2 EUROPE TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
- 6.2.1 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
- 6.2.2 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)

7 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES BY REGION

7.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY REGION
- 7.1.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2017-2022)
- 7.1.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2017-2022)
7.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY REGION
- 7.2.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2023-2028)
- 7.2.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2023-2028)

8 SOUTH AMERICA TRANSDERMAL DRUG PATCHES BY COUNTRY

8.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
- 8.1.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
- 8.1.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
8.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
- 8.2.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
- 8.2.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)

9 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES BY COUNTRY

9.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
- 9.1.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
- 9.1.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
9.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
- 9.2.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
- 9.2.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)

10 COMPANY PROFILES AND KEY FIGURES IN TRANSDERMAL DRUG PATCHES BUSINESS

10.1 HISAMITSU PHARMACEUTICAL
- 10.1.1 HISAMITSU PHARMACEUTICAL CORPORATION INFORMATION
- 10.1.2 HISAMITSU PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW
- 10.1.3 HISAMITSU PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.1.4 HISAMITSU PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.2 JOHNSON & JOHNSON
- 10.2.1 JOHNSON & JOHNSON CORPORATION INFORMATION
- 10.2.2 JOHNSON & JOHNSON INTRODUCTION AND BUSINESS OVERVIEW
- 10.2.3 JOHNSON & JOHNSON TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.2.4 JOHNSON & JOHNSON TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.3 MYLAN
- 10.3.1 MYLAN CORPORATION INFORMATION
- 10.3.2 MYLAN INTRODUCTION AND BUSINESS OVERVIEW
- 10.3.3 MYLAN TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.3.4 MYLAN TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.4 UCB PHARMA
- 10.4.1 UCB PHARMA CORPORATION INFORMATION
- 10.4.2 UCB PHARMA INTRODUCTION AND BUSINESS OVERVIEW
- 10.4.3 UCB PHARMA TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.4.4 UCB PHARMA TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.5 NOVARTIS
- 10.5.1 NOVARTIS CORPORATION INFORMATION
- 10.5.2 NOVARTIS INTRODUCTION AND BUSINESS OVERVIEW
- 10.5.3 NOVARTIS TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.5.4 NOVARTIS TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.6 TEVA PHARMACEUTICAL
- 10.6.1 TEVA PHARMACEUTICAL CORPORATION INFORMATION
- 10.6.2 TEVA PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW
- 10.6.3 TEVA PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.6.4 TEVA PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.7 BEIJING TIDE PHARMACEUTICAL
- 10.7.1 BEIJING TIDE PHARMACEUTICAL CORPORATION INFORMATION
- 10.7.2 BEIJING TIDE PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW
- 10.7.3 BEIJING TIDE PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.7.4 BEIJING TIDE PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.8 CHATTEM
- 10.8.1 CHATTEM CORPORATION INFORMATION
- 10.8.2 CHATTEM INTRODUCTION AND BUSINESS OVERVIEW
- 10.8.3 CHATTEM TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.8.4 CHATTEM TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.9 NITTO DENKO
- 10.9.1 NITTO DENKO CORPORATION INFORMATION
- 10.9.2 NITTO DENKO INTRODUCTION AND BUSINESS OVERVIEW
- 10.9.3 NITTO DENKO TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.9.4 NITTO DENKO TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.10 Grunenthal
- 10.10.1 Grunenthal CORPORATION INFORMATION
- 10.10.2 Grunenthal INTRODUCTION AND BUSINESS OVERVIEW
- 10.10.3 Grunenthal TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.10.4 Grunenthal TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.11 MUNDIPHARMA
- 10.11.1 MUNDIPHARMA CORPORATION INFORMATION
- 10.11.2 MUNDIPHARMA INTRODUCTION AND BUSINESS OVERVIEW
- 10.11.3 MUNDIPHARMA TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.11.4 MUNDIPHARMA TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.12 GSK
- 10.12.1 GSK CORPORATION INFORMATION
- 10.12.2 GSK INTRODUCTION AND BUSINESS OVERVIEW
- 10.12.3 GSK TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.12.4 GSK TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.13 LUYE PHARMA GROUP
- 10.13.1 LUYE PHARMA GROUP CORPORATION INFORMATION
- 10.13.2 LUYE PHARMA GROUP INTRODUCTION AND BUSINESS OVERVIEW
- 10.13.3 LUYE PHARMA GROUP TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.13.4 LUYE PHARMA GROUP TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.14 BAYER
- 10.14.1 BAYER CORPORATION INFORMATION
- 10.14.2 BAYER INTRODUCTION AND BUSINESS OVERVIEW
- 10.14.3 BAYER TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.14.4 BAYER TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.15 IBSA GROUP
- 10.15.1 IBSA GROUP CORPORATION INFORMATION
- 10.15.2 IBSA GROUP INTRODUCTION AND BUSINESS OVERVIEW
- 10.15.3 IBSA GROUP TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.15.4 IBSA GROUP TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.16 Dr Reddy's Laboratories
- 10.16.1 Dr Reddy's Laboratories CORPORATION INFORMATION
- 10.16.2 Dr Reddy's Laboratories INTRODUCTION AND BUSINESS OVERVIEW
- 10.16.3 Dr Reddy's Laboratories TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.16.4 Dr Reddy's Laboratories TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED

11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

11.1 TRANSDERMAL DRUG PATCHES KEY RAW MATERIALS
- 11.1.1 KEY RAW MATERIALS
- 11.1.2 RAW MATERIALS KEY SUPPLIERS
11.2 MANUFACTURING COST STRUCTURE
- 11.2.1 RAW MATERIALS
- 11.2.2 LABOR COST
- 11.2.3 MANUFACTURING EXPENSES
11.3 TRANSDERMAL DRUG PATCHES INDUSTRIAL CHAIN ANALYSIS
11.4 TRANSDERMAL DRUG PATCHES MARKET DYNAMICS
- 11.4.1 TRANSDERMAL DRUG PATCHES INDUSTRY TRENDS
- 11.4.2 TRANSDERMAL DRUG PATCHES MARKET DRIVERS
- 11.4.3 TRANSDERMAL DRUG PATCHES MARKET CHALLENGES
- 11.4.4 TRANSDERMAL DRUG PATCHES MARKET RESTRAINTS

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS

12.1 SALES CHANNEL
12.2 TRANSDERMAL DRUG PATCHES DISTRIBUTORS
12.3 TRANSDERMAL DRUG PATCHES DOWNSTREAM CUSTOMERS

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 RESEARCH METHODOLOGY
- 14.1.1 METHODOLOGY/RESEARCH APPROACH
- 14.1.2 DATA SOURCE
14.2 AUTHOR DETAILS
14.3 DISCLAIMER

LIST OF TABLES

Table 1. Global Transdermal Drug Patches Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 2. Global Transdermal Drug Patches Sales by Type (2017-2022) & (M Pieces)
Table 3. Global Transdermal Drug Patches Sales Market Share in Volume by Type (2017-2022)
Table 4. Global Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 5. Global Transdermal Drug Patches Sales Market Share in Value by Type (2017-2022)
Table 6. Global Transdermal Drug Patches Price by Type (2017-2022) & (USD/Piece)
Table 7. Global Transdermal Drug Patches Sales by Type (2023-2028) & (M Pieces)
Table 8. Global Transdermal Drug Patches Sales Market Share in Volume by Type (2023-2028)
Table 9. Global Transdermal Drug Patches Sales by Type (2023-2028) & (US$ Million)
Table 10. Global Transdermal Drug Patches Sales Market Share in Value by Type (2023-2028)
Table 11. Global Transdermal Drug Patches Price by Type (2023-2028) & (USD/Piece)
Table 12. North America Transdermal Drug Patches Sales by Type (2017-2022) & (M Pieces)
Table 13. North America Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 14. Europe Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
Table 15. Europe Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 16. Asia-Pacific Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
Table 17. Asia-Pacific Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 18. South America Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
Table 19. South America Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 20. Middle East and Africa Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
Table 21. Middle East and Africa Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 22. Global Transdermal Drug Patches Sales by Company (2017-2022) & (M Pieces)
Table 23. Global Transdermal Drug Patches Sales Share by Company (2017-2022)
Table 24. Global Transdermal Drug Patches Revenue by Company (2017-2022) & (US$ Million)
Table 25. Global Transdermal Drug Patches Revenue Share by Company (2017-2022)
Table 26. Global Market Transdermal Drug Patches Price by Company (2017-2022) & (USD/Piece)
Table 27. Global Transdermal Drug Patches Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Patches as of 2021)
Table 29. Key Manufacturers Transdermal Drug Patches Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Transdermal Drug Patches Market Size Comparison by Region (US$ Million): 2017 VS 2022 VS 2028
Table 32. Global Transdermal Drug Patches Sales by Region (2017-2022) & (M Pieces)
Table 33. Global Transdermal Drug Patches Sales Market Share in Volume by Region (2017-2022)
Table 34. Global Transdermal Drug Patches Sales by Region (2017-2022) & (US$ Million)
Table 35. Global Transdermal Drug Patches Sales Market Share in Value by Region (2017-2022)
Table 36. Global Transdermal Drug Patches Sales (M Pieces), Value (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 37. Global Transdermal Drug Patches Sales by Region (2023-2028) & (M Pieces)
Table 38. Global Transdermal Drug Patches Sales Market Share in Volume by Region (2023-2028)
Table 39. Global Transdermal Drug Patches Sales by Region (2023-2028) & (US$ Million)
Table 40. Global Transdermal Drug Patches Sales Market Share in Value by Region (2023-2028)
Table 41. Global Transdermal Drug Patches Sales (M Pieces), Value (US$ Million), Price (USD/Piece) and Gross Margin (2023-2028)
Table 42. Global Transdermal Drug Patches Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 43. Global Transdermal Drug Patches Sales by Application (2017-2022) & (M Pieces)
Table 44. Global Transdermal Drug Patches Sales Market Share in Volume by Application (2017-2022)
Table 45. Global Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million)
Table 46. Global Transdermal Drug Patches Sales Market Share in Value by Application (2017-2022)
Table 47. Global Transdermal Drug Patches Price by Application (2017-2022) & (USD/Piece)
Table 48. Global Transdermal Drug Patches Sales by Application (2023-2028) & (M Pieces)
Table 49. Global Transdermal Drug Patches Sales Market Share in Volume by Application (2023-2028)
Table 50. Global Transdermal Drug Patches Sales by Application (2023-2028) & (US$ Million)
Table 51. Global Transdermal Drug Patches Sales Market Share in Value by Application (2023-2028)
Table 52. Global Transdermal Drug Patches Price by Application (2023-2028) & (USD/Piece)
Table 53. North America Transdermal Drug Patches Sales by Application (2017-2022) & (M Pieces)
Table 54. North America Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million)
Table 55. Europe Transdermal Drug Patches Sales (M Pieces) by Application (2017-2022)
Table 56. Europe Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million)
Table 57. Asia-Pacific Transdermal Drug Patches Sales (M Pieces) by Application (2017-2022)
Table 58. Asia-Pacific Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million)
Table 59. South America Transdermal Drug Patches Sales (M Pieces) by Application (2017-2022)
Table 60. South America Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Transdermal Drug Patches Sales (M Pieces) by Application (2017-2022)
Table 62. Middle East and Africa Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million)
Table 63. North America Transdermal Drug Patches Sales by Country (2017-2022) & (M Pieces)
Table 64. North America Transdermal Drug Patches Sales Market Share in Volume by Country (2017-2022)
Table 65. North America Transdermal Drug Patches Sales by Country (2017-2022) & (US$ Million)
Table 66. North America Transdermal Drug Patches Sales Market Share in Value by Country (2017-2022)
Table 67. North America Transdermal Drug Patches Sales by Country (2023-2028) & (M Pieces)
Table 68. North America Transdermal Drug Patches Sales Market Share in Volume by Country (2023-2028)
Table 69. North America Transdermal Drug Patches Sales by Country (2023-2028) & (US$ Million)
Table 70. North America Transdermal Drug Patches Sales Market Share in Value by Country (2023-2028)
Table 71. Europe Transdermal Drug Patches Sales by Country (2017-2022) & (M Pieces)
Table 72. Europe Transdermal Drug Patches Sales Market Share in Volume by Country (2017-2022)
Table 73. Europe Transdermal Drug Patches Sales by Country (2017-2022) & (US$ Million)
Table 74. Europe Transdermal Drug Patches Sales Market Share in Value by Country (2017-2022)
Table 75. Europe Transdermal Drug Patches Sales by Country (2023-2028) & (M Pieces)
Table 76. Europe Transdermal Drug Patches Sales Market Share in Volume by Country (2023-2028)
Table 77. Europe Transdermal Drug Patches Sales by Country (2023-2028) & (US$ Million)
Table 78. Europe Transdermal Drug Patches Sales Market Share in Value by Country (2023-2028)
Table 79. Asia-Pacific Transdermal Drug Patches Sales by Region (2017-2022) & (M Pieces)
Table 80. Asia-Pacific Transdermal Drug Patches Sales Market Share in Volumeby Region (2017-2022)
Table 81. Asia-Pacific Transdermal Drug Patches Sales by Region (2017-2022) & (US$ Million)
Table 82. Asia-Pacific Transdermal Drug Patches Sales Market Share in Value by Region (2017-2022)
Table 83. Asia-Pacific Transdermal Drug Patches Sales by Region (2023-2028) & (M Pieces)
Table 84. Asia-Pacific Transdermal Drug Patches Sales Market Share in Volume by Region (2023-2028)
Table 85. Asia-Pacific Transdermal Drug Patches Sales by Region (2023-2028) & (US$ Million)
Table 86. Asia-Pacific Transdermal Drug Patches Sales Market Share in Value by Region (2023-2028)
Table 87. South America Transdermal Drug Patches Sales by Country (2017-2022) & (M Pieces)
Table 88. South America Transdermal Drug Patches Sales Market Share in Volume by Country (2017-2022)
Table 89. South America Transdermal Drug Patches Sales by Country (2017-2022) & (US$ Million)
Table 90. South America Transdermal Drug Patches Sales Market Share in Value by Country (2017-2022)
Table 91. South America Transdermal Drug Patches Sales by Country (2023-2028) & (M Pieces)
Table 92. South America Transdermal Drug Patches Sales Market Share in Volume by Country (2023-2028)
Table 93. South America Transdermal Drug Patches Sales by Country (2023-2028) & (US$ Million)
Table 94. South America Transdermal Drug Patches Sales Market Share in Value by Country (2023-2028)
Table 95. Middle East and Africa Transdermal Drug Patches Sales by Country (2017-2022) & (M Pieces)
Table 96. Middle East and Africa Transdermal Drug Patches Sales Market Share in Volume by Country (2017-2022)
Table 97. Middle East and Africa Transdermal Drug Patches Sales by Country (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Transdermal Drug Patches Sales Market Share in Value by Country (2017-2022)
Table 99. Middle East and Africa Transdermal Drug Patches Sales by Country (2023-2028) & (M Pieces)
Table 100. Middle East and Africa Transdermal Drug Patches Sales Market Share by Country (2023-2028)
Table 101. Middle East and Africa Transdermal Drug Patches Sales by Country (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Transdermal Drug Patches Sales Market Share in Value by Country (2023-2028)
Table 103. Hisamitsu Pharmaceutical Corporation Information
Table 104. Hisamitsu Pharmaceutical Introduction and Business Overview
Table 105. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 106. Hisamitsu Pharmaceutical Transdermal Drug Patches Product
Table 107. Johnson & Johnson Corporation Information
Table 108. Johnson & Johnson Introduction and Business Overview
Table 109. Johnson & Johnson Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 110. Johnson & Johnson Transdermal Drug Patches Product
Table 111. Mylan Corporation Information
Table 112. Mylan Introduction and Business Overview
Table 113. Mylan Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 114. Mylan Transdermal Drug Patches Product
Table 115. UCB Pharma Corporation Information
Table 116. UCB Pharma Introduction and Business Overview
Table 117. UCB Pharma Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 118. UCB Pharma Transdermal Drug Patches Product
Table 119. Novartis Corporation Information
Table 120. Novartis Introduction and Business Overview
Table 121. Novartis Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 122. Novartis Transdermal Drug Patches Product
Table 123. Teva Pharmaceutical Corporation Information
Table 124. Teva Pharmaceutical Introduction and Business Overview
Table 125. Teva Pharmaceutical Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 126. Teva Pharmaceutical Transdermal Drug Patches Product
Table 127. Beijing Tide Pharmaceutical Corporation Information
Table 128. Beijing Tide Pharmaceutical Introduction and Business Overview
Table 129. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 130. Beijing Tide Pharmaceutical Transdermal Drug Patches Product
Table 131. Chattem Corporation Information
Table 132. Chattem Introduction and Business Overview
Table 133. Chattem Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 134. Chattem Transdermal Drug Patches Product
Table 135. Nitto Denko Corporation Information
Table 136. Nitto Denko Introduction and Business Overview
Table 137. Nitto Denko Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 138. Nitto Denko Transdermal Drug Patches Product
Table 139. Grunenthal Corporation Information
Table 140. Grunenthal Introduction and Business Overview
Table 141. Grunenthal Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 142. Grunenthal Transdermal Drug Patches Product
Table 143. Mundipharma Corporation Information
Table 144. Mundipharma Introduction and Business Overview
Table 145. Mundipharma Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 146. Mundipharma Transdermal Drug Patches Product
Table 147. GSK Corporation Information
Table 148. GSK Introduction and Business Overview
Table 149. GSK Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 150. GSK Transdermal Drug Patches Product
Table 151. Luye Pharma Group Corporation Information
Table 152. Luye Pharma Group Introduction and Business Overview
Table 153. Luye Pharma Group Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 154. Luye Pharma Group Transdermal Drug Patches Product
Table 155. Bayer Corporation Information
Table 156. Bayer Introduction and Business Overview
Table 157. Bayer Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 158. Bayer Transdermal Drug Patches Product
Table 159. IBSA Group Corporation Information
Table 160. IBSA Group Introduction and Business Overview
Table 161. IBSA Group Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 162. IBSA Group Transdermal Drug Patches Product
Table 163. Dr Reddy's Laboratories Corporation Information
Table 164. Dr Reddy's Laboratories Introduction and Business Overview
Table 165. Dr Reddy's Laboratories Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
Table 166. Dr Reddy's Laboratories Transdermal Drug Patches Product
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Transdermal Drug Patches Market Trends
Table 170. Transdermal Drug Patches Market Drivers
Table 171. Transdermal Drug Patches Market Challenges
Table 172. Transdermal Drug Patches Market Restraints
Table 173. Transdermal Drug Patches Distributors List
Table 174. Transdermal Drug Patches Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Transdermal Patch
Figure 2. Global Transdermal Drug Patches Market Size, 2017 VS 2022 VS 2028 (US$ Million)
Figure 3. Global Transdermal Drug Patches Market Size Status and Outlook (2017-2028) & (US$ Million)
Figure 4. Global Transdermal Drug Patches Sales Status and Outlook (2017-2028) & (M Pieces)
Figure 5. Methyl Salicylate-based Patch Product Picture
Figure 6. Rivastigmine Transdermal Patch Product Picture
Figure 7. Fentanyl Transdermal Patch Product Picture
Figure 8. Lidocaine Patch Product Picture
Figure 9. Diclofenac Patch Product Picture
Figure 10. Nicotine Transdermal Patch Product Picture
Figure 11. Global Transdermal Drug Patches Sales by Type (2017-2028) & (US$ Million)
Figure 12. Global Transdermal Drug Patches Market Share by Type in 2022 & 2028
Figure 13. North America Transdermal Drug Patches Sales Market Share in Volume by Type in 2021
Figure 14. North America Transdermal Drug Patches Sales Market Share in Value by Type in 2021
Figure 15. Europe Transdermal Drug Patches Sales Market Share in Volume by Type in 2021
Figure 16. Europe Transdermal Drug Patches Sales Market Share in Value by Type in 2021
Figure 17. Asia-Pacific Transdermal Drug Patches Sales Market Share in Volume by Type in 2021
Figure 18. Asia-Pacific Transdermal Drug Patches Sales Market Share in Value by Type in 2021
Figure 19. South America Transdermal Drug Patches Sales Market Share in Volume by Type in 2021
Figure 20. South America Transdermal Drug Patches Sales Market Share in Value by Type in 2021
Figure 21. Middle East and Africa Transdermal Drug Patches Sales Market Share in Volume by Type in 2021
Figure 22. Middle East and Africa Transdermal Drug Patches Sales Market Share in Value by Type in 2021
Figure 23. Global Transdermal Drug Patches Sales Share by Company in 2021
Figure 24. Global Transdermal Drug Patches Revenue Share by Company in 2021
Figure 25. The 5 Largest Manufacturers in the World: Market Share by Transdermal Drug Patches Revenue in 2021
Figure 26. Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 27. Rx Channel
Figure 28. OTC Channel
Figure 29. Global Transdermal Drug Patches Sales by Application (2017-2028) & (US$ Million)
Figure 30. Global Transdermal Drug Patches Market Share by Application in 2022 & 2028
Figure 31. North America Transdermal Drug Patches Sales Market Share in Volume by Application in 2021
Figure 32. North America Transdermal Drug Patches Sales Market Share in Value by Application in 2021
Figure 33. Europe Transdermal Drug Patches Sales Market Share in Volume by Application in 2021
Figure 34. Europe Transdermal Drug Patches Sales Market Share in Value by Application in 2021
Figure 35. Asia-Pacific Transdermal Drug Patches Sales Market Share in Volume by Application in 2021
Figure 36. Asia-Pacific Transdermal Drug Patches Sales Market Share in Value by Application in 2021
Figure 37. South America Transdermal Drug Patches Sales Market Share in Volume by Application in 2021
Figure 38. South America Transdermal Drug Patches Sales Market Share in Value by Application in 2021
Figure 39. Middle East and Africa Transdermal Drug Patches Sales Market Share in Volume by Application in 2021
Figure 40. Middle East and Africa Transdermal Drug Patches Sales Market Share in Value by Application in 2021
Figure 41. Transdermal Drug Patches Manufacturing Cost Structure
Figure 42. Transdermal Drug Patches Industrial Chain Analysis
Figure 43. Channels of Distribution
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed